The following section deals with manufacturing technologies of Pharmaceuticals and up-to-date pharmaceutical equipment
argenx, a clinical-stage biotechnology company developing a deep pipeline of differentiated antibody-based therapies, received a €2.5 million grant from Flanders Innovation and Entrepreneurship (VLAIO).
LabCorp, a leading global life sciences company, announced that its Covance Drug Development business has formed a global immunology and immunotoxicology (I&I) unit dedicated to the specific needs of biologic drug development.
Researchers said that biocompatible implants might be widely used in medicine for replacing body tissues and elements of vital internal organs ranging from finger joints to heart valves.
Russian Pharmaceutical Technologies (Ruspharmtech, a SKOLKOVO resident) has increased the commercial value of its patent portfolio by obtaining a US patent.
Merus N.V., a Dutch clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics, announced that Ono Pharmaceutical has exercised its option to enter into a new research and license agreement
Researchers at the Irkutsk Institute of Chemistry of the Siberian Branch of the Russian Academy of Sciences synthesized a substance that protects against flu virus, including H1N1, better known as swine flu.
The scientists at the Kemerovo State Agricultural Institute are developing phytobiotics from Siberian herbs; it is expected that the drugs would be able to replace similar imported additives and antibiotics
Rosatom State Corporation has the capacity for developing the medical part of its activities. This opinion was expressed by Sergey Tsyb, the Deputy Minister of Industry and Trade of the Russian Federation.